Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05518461 · ClinicalTrials.gov registry record · NA
Smartphone Intervention for Overdose and COVID-19
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT05518461 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 60 participants.
The verdict
NCT05518461, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study will examine if the use of a smartphone application called Thrive4Life Connect can help people who use drugs lower their risk of overdose and learn more about COVID-19 vaccines. 60 participants will be enrolled and can expect to be on study for up to 6 months.
Interventions
- DEVICE iThrive WI Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-12-19 |
| Est. Completion | 2023-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05518461
The ClinicalTrials.gov registry entry for NCT05518461 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which iThrive WI Intervention is the first listed.
NCT05518461 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05518461 about?
NCT05518461 is a clinical study titled "Smartphone Intervention for Overdose and COVID-19". This study will examine if the use of a smartphone application called Thrive4Life Connect can help people who use drugs lower their risk of overdose and learn more about COVID-19 vaccines. 60 participants will be enrolled and can expect to be on study for up to 6 months.
What is the current status of trial NCT05518461?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2022-12-19. Estimated completion is 2023-12-15.
What interventions are being tested in trial NCT05518461?
The interventions under investigation include: iThrive WI Intervention (DEVICE).
Who is sponsoring clinical trial NCT05518461?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.